



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Learn about Surface Plasmon Resonance (SPR) technology and its applications in drug discovery, particularly in target identification, ligand screening, and lead compound selection. Discover Creative Biostructure's MagHelix™ SPR services, which offer sensitive, rapid, and reliable assays for measuring real-time binding and kinetic information of ligands against specific targets.
Typology: Slides
1 / 6
This page cannot be seen from the preview
Don't miss anything!




Briefly, the advantages of SPR include: 1) It is highly sensitive and suitable for detecting weak target-
ligand interactions mediated by fragments; 2) Without labels and the detection of false positives caused
by fluorescence quenching can be excluded; 3) Relatively small quantities of samples can be used for
measuring real-time quantitative kinetics and binding affinity; 4) The medium-throughput mode makes
it available as a tool for screening ligands. However, information about the binding site or
pharmacophore of a ligand cannot be obtained.
Advantages of our MagHelix™ Surface Plasmon Resonance (SPR) services:
Based on powerful Biacore and Fortebio systems, we have provided customers with many high-quality
solutions for monitoring interactions between various proteins, DNA/RNA as well as small/complex
molecules.
We have many years of experience in monitoring biomolecular interactions such as protein-small
molecule, protein-peptide, protein-protein, antigen-antibody, and so on.
We can combine SPR technology with fragment-based screening approach for medium-throughput
screening of chemical libraries.
The next-generation SPR instruments enable us to analyze the ligand binding to membrane proteins in
a more native environment.
Using SPR technology to screen and characterize antibodies to understand their affinity and kinetic
characteristics.
At Creative Biostructure , we can offer corresponding compound libraries or fragment libraries for ligand
screening, and we also provide other
biophysical solutions to characterize the binding kinetics of hit compounds or fragments. Want to know
more? Please do not hesitate to contact us for more information.
References
1.Cooper M A. Optical biosensors in drug discovery. Nature reviews Drug discovery. 2002, 1(7): 515-528.
2.Patching S G. Surface plasmon resonance spectroscopy for characterisation of membrane protein-
ligand interactions and its potential for drug discovery. Biochimica et Biophysica Acta (BBA)-Biomembranes.
Related Services:
MagHelix™ Bio-layer Interferometry (BLI)
MagHelix™ Saturation Transfer Difference (STD) NMR
MagHelix™ Co-crystallization and Soaking
MagHelix™ Differential Scanning Calorimetry (DSC)
MagHelix™ Dynamic Light Scattering (DLS)